The latest study on Patient Derived Xenograft/PDX Models Market by Read Market Research provides a detailed summary and overview of the global market. The base year considered in this report is considered 2020 whereas information for 2021 is estimated and forecast from 2022 till 2027. The CAGR (Compound Annual Growth Rate) period of this report is 2021-2027. The Global Patient Derived Xenograft/PDX Models Market is valued at USD XX Million in the year 2020 and is estimated to grow at USD XX Million by the end of year 2027.The report will shed light on very important growth aspect of Patient Derived Xenograft/PDX Models and is a must have data for all the companies, investors, decision makers, top level executives and readers.
The segmental analysis of the report provides detailed analysis on Revenue, Growth, Forecast By Region, Type and Applications for the period 2016-2027.
The major vendors covered:
Crown Bioscience
The Jackson Laboratory
Champions Oncology
Charles River Laboratories
WuXi Apptec
Oncodesign
Horizon Discovery
Pharmatest Services
Hera Biolabs
EPO Berlin-Buch
Xentech
Urolead
Patient Derived Xenograft/PDX Models Market Analysis By Type Segment:
Mice Models
Rat Models
Patient Derived Xenograft/PDX Models Market Analysis By Application Segment:
Pre-clinical Drug Development and Basic Cancer Research
Biomarker Analysis
Patient Derived Xenograft/PDX Models Market Analysis By Regions (Countries):
The Patient Derived Xenograft/PDX Models Market has been thoroughly researched with the help of Primary and Secondary Research and has been validated by conduction interviews with industry experts across all the regions. As it is global study, we have included all the major regions.
Bottom Up approach has been used to derive and define the market size and shares of regions. Regions such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. has been taken into consideration while deriving the market size and shares of regions.
Key Details of Regions and Countries of Patient Derived Xenograft/PDX Models Report:
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa
Key data provided:
Market Size of Regions
Market Share of Regions
Compound Annual Growth Rate (CAGR)
Historic Data From 2016-2020
Forecast Data From 2021-2027
Competitive Landscape of Patient Derived Xenograft/PDX Models Market:
Patient Derived Xenograft/PDX Models market competitive landscape analysis sheds light on the current market structure by players. The report will help the readers to understand some most important questions of the global market.
Key Questions Answered in Competitive Landscape-
List of Key Players
Revenue By players
Market share of players
Product Offerings
The study objectives are:
To analyze and research the Patient Derived Xenograft/PDX Models Market status and future forecast.
To present the key Patient Derived Xenograft/PDX Models Market analysis of companies and present revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Patient Derived Xenograft/PDX Models Market Size Growth Rate by Type (2016-2027)
1.4.2 Mice Models
1.4.3 Rat Models
1.5 Market by Application
1.5.1 Global Patient Derived Xenograft/PDX Models Market Share by Application (2016-2027)
1.5.2 Pre-clinical Drug Development and Basic Cancer Research
1.5.3 Biomarker Analysis
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Patient Derived Xenograft/PDX Models Market Size
2.2 Patient Derived Xenograft/PDX Models Growth Trends by Regions
2.2.1 Patient Derived Xenograft/PDX Models Market Size by Regions (2016-2027)
2.2.2 Patient Derived Xenograft/PDX Models Market Share by Regions (2016-2020)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Patient Derived Xenograft/PDX Models Market Size by Manufacturers
3.1.1 Global Patient Derived Xenograft/PDX Models Revenue by Manufacturers (2020)
3.1.2 Global Patient Derived Xenograft/PDX Models Revenue Market Share by Manufacturers (2020)
3.1.3 Global Patient Derived Xenograft/PDX Models Market Concentration Ratio (CR5 and HHI)
3.2 Patient Derived Xenograft/PDX Models Key Players Head office and Area Served
3.3 Key Players Patient Derived Xenograft/PDX Models Product/Solution/Service
3.4 Date of Enter into Patient Derived Xenograft/PDX Models Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Patient Derived Xenograft/PDX Models Market Size by Type (2016-2020)
4.2 Global Patient Derived Xenograft/PDX Models Market Size by Application (2016-2020)
5 United States
5.1 United States Patient Derived Xenograft/PDX Models Market Size (2016-2020)
5.2 Patient Derived Xenograft/PDX Models Key Players in United States
5.3 United States Patient Derived Xenograft/PDX Models Market Size by Type
5.4 United States Patient Derived Xenograft/PDX Models Market Size by Application
6 Europe
6.1 Europe Patient Derived Xenograft/PDX Models Market Size (2016-2020)
6.2 Patient Derived Xenograft/PDX Models Key Players in Europe
6.3 Europe Patient Derived Xenograft/PDX Models Market Size by Type
6.4 Europe Patient Derived Xenograft/PDX Models Market Size by Application
7 China
7.1 China Patient Derived Xenograft/PDX Models Market Size (2016-2020)
7.2 Patient Derived Xenograft/PDX Models Key Players in China
7.3 China Patient Derived Xenograft/PDX Models Market Size by Type
7.4 China Patient Derived Xenograft/PDX Models Market Size by Application
8 Japan
8.1 Japan Patient Derived Xenograft/PDX Models Market Size (2016-2020)
8.2 Patient Derived Xenograft/PDX Models Key Players in Japan
8.3 Japan Patient Derived Xenograft/PDX Models Market Size by Type
8.4 Japan Patient Derived Xenograft/PDX Models Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Patient Derived Xenograft/PDX Models Market Size (2016-2020)
9.2 Patient Derived Xenograft/PDX Models Key Players in Southeast Asia
9.3 Southeast Asia Patient Derived Xenograft/PDX Models Market Size by Type
9.4 Southeast Asia Patient Derived Xenograft/PDX Models Market Size by Application
10 India
10.1 India Patient Derived Xenograft/PDX Models Market Size (2016-2020)
10.2 Patient Derived Xenograft/PDX Models Key Players in India
10.3 India Patient Derived Xenograft/PDX Models Market Size by Type
10.4 India Patient Derived Xenograft/PDX Models Market Size by Application
11 Central & South America
11.1 Central & South America Patient Derived Xenograft/PDX Models Market Size (2016-2020)
11.2 Patient Derived Xenograft/PDX Models Key Players in Central & South America
11.3 Central & South America Patient Derived Xenograft/PDX Models Market Size by Type
11.4 Central & South America Patient Derived Xenograft/PDX Models Market Size by Application
12 International Players Profiles
12.1 Crown Bioscience
12.1.1 Crown Bioscience Company Details
12.1.2 Company Description and Business Overview
12.1.3 Patient Derived Xenograft/PDX Models Introduction
12.1.4 Crown Bioscience Revenue in Patient Derived Xenograft/PDX Models Business (2020)
12.1.5 Crown Bioscience Recent Development
12.2 The Jackson Laboratory
12.2.1 The Jackson Laboratory Company Details
12.2.2 Company Description and Business Overview
12.2.3 Patient Derived Xenograft/PDX Models Introduction
12.2.4 The Jackson Laboratory Revenue in Patient Derived Xenograft/PDX Models Business (2020)
12.2.5 The Jackson Laboratory Recent Development
12.3 Champions Oncology
12.3.1 Champions Oncology Company Details
12.3.2 Company Description and Business Overview
12.3.3 Patient Derived Xenograft/PDX Models Introduction
12.3.4 Champions Oncology Revenue in Patient Derived Xenograft/PDX Models Business (2020)
12.3.5 Champions Oncology Recent Development
12.4 Charles River Laboratories
12.4.1 Charles River Laboratories Company Details
12.4.2 Company Description and Business Overview
12.4.3 Patient Derived Xenograft/PDX Models Introduction
12.4.4 Charles River Laboratories Revenue in Patient Derived Xenograft/PDX Models Business (2020)
12.4.5 Charles River Laboratories Recent Development
12.5 WuXi Apptec
12.5.1 WuXi Apptec Company Details
12.5.2 Company Description and Business Overview
12.5.3 Patient Derived Xenograft/PDX Models Introduction
12.5.4 WuXi Apptec Revenue in Patient Derived Xenograft/PDX Models Business (2020)
12.5.5 WuXi Apptec Recent Development
12.6 Oncodesign
12.6.1 Oncodesign Company Details
12.6.2 Company Description and Business Overview
12.6.3 Patient Derived Xenograft/PDX Models Introduction
12.6.4 Oncodesign Revenue in Patient Derived Xenograft/PDX Models Business (2020)
12.6.5 Oncodesign Recent Development
12.7 Horizon Discovery
12.7.1 Horizon Discovery Company Details
12.7.2 Company Description and Business Overview
12.7.3 Patient Derived Xenograft/PDX Models Introduction
12.7.4 Horizon Discovery Revenue in Patient Derived Xenograft/PDX Models Business (2020)
12.7.5 Horizon Discovery Recent Development
12.8 Pharmatest Services
12.8.1 Pharmatest Services Company Details
12.8.2 Company Description and Business Overview
12.8.3 Patient Derived Xenograft/PDX Models Introduction
12.8.4 Pharmatest Services Revenue in Patient Derived Xenograft/PDX Models Business (2020)
12.8.5 Pharmatest Services Recent Development
12.9 Hera Biolabs
12.9.1 Hera Biolabs Company Details
12.9.2 Company Description and Business Overview
12.9.3 Patient Derived Xenograft/PDX Models Introduction
12.9.4 Hera Biolabs Revenue in Patient Derived Xenograft/PDX Models Business (2020)
12.9.5 Hera Biolabs Recent Development
12.10 EPO Berlin-Buch
12.10.1 EPO Berlin-Buch Company Details
12.10.2 Company Description and Business Overview
12.10.3 Patient Derived Xenograft/PDX Models Introduction
12.10.4 EPO Berlin-Buch Revenue in Patient Derived Xenograft/PDX Models Business (2020)
12.10.5 EPO Berlin-Buch Recent Development
12.11 Xentech
12.12 Urolead
13 Market Forecast 2021-2027
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2021-2027)
13.10 Market Size Forecast by Application (2021-2027)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
List of Tables and Figures
List of Tables and Figures
Table Patient Derived Xenograft/PDX Models Key Market Segments
Table Key Players Patient Derived Xenograft/PDX Models Covered
Table Global Patient Derived Xenograft/PDX Models Market Size Growth Rate by Type 2016-2027 (Million US$)
Figure Global Patient Derived Xenograft/PDX Models Market Size Market Share by Type 2016-2027
Figure Mice Models Figures
Table Key Players of Mice Models
Figure Rat Models Figures
Table Key Players of Rat Models
Table Global Patient Derived Xenograft/PDX Models Market Size Growth by Application 2016-2027 (Million US$)
Figure Pre-clinical Drug Development and Basic Cancer Research Case Studies
Figure Biomarker Analysis Case Studies
Figure Patient Derived Xenograft/PDX Models Report Years Considered
Table Global Patient Derived Xenograft/PDX Models Market Size 2016-2027 (Million US$)
Figure Global Patient Derived Xenograft/PDX Models Market Size and Growth Rate 2016-2027 (Million US$)
Table Global Patient Derived Xenograft/PDX Models Market Size by Regions 2016-2027 (Million US$)
Table Global Patient Derived Xenograft/PDX Models Market Size by Regions 2016-2020 (Million US$)
Table Global Patient Derived Xenograft/PDX Models Market Share by Regions 2016-2020
Figure Global Patient Derived Xenograft/PDX Models Market Share by Regions 2016-2020
Figure Global Patient Derived Xenograft/PDX Models Market Share by Regions 2020
Table Market Top Trends
Table Global Patient Derived Xenograft/PDX Models Revenue by Manufacturers (2020) (Million US$)
Table Global Patient Derived Xenograft/PDX Models Market Share by Manufacturers (2020)
Figure Global Patient Derived Xenograft/PDX Models Market Share by Manufacturers in 2020
Table Global Patient Derived Xenograft/PDX Models Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Patient Derived Xenograft/PDX Models Product/Solution/Service
Table Date of Enter into Patient Derived Xenograft/PDX Models Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Patient Derived Xenograft/PDX Models Market Size by Type (2016-2020) (Million US$)
Table Global Patient Derived Xenograft/PDX Models Market Size Share by Type (2016-2020)
Figure Global Patient Derived Xenograft/PDX Models Market Size Market Share by Type (2016-2020)
Table Global Patient Derived Xenograft/PDX Models Market Size by Application (2016-2020) (Million US$)
Table Global Patient Derived Xenograft/PDX Models Market Size Share by Application (2016-2020)
Figure Global Patient Derived Xenograft/PDX Models Market Size Market Share by Application (2016-2020)
Figure Global Patient Derived Xenograft/PDX Models Revenue Market Share by Application in 2020
Figure United States Patient Derived Xenograft/PDX Models Market Size 2016-2020 (Million US$)
Table United States Key Players Patient Derived Xenograft/PDX Models Revenue (2020) (Million US$)
Table United States Key Players Patient Derived Xenograft/PDX Models Market Share (2020)
Table United States Patient Derived Xenograft/PDX Models Market Size by Type (2016-2020) (Million US$)
Table United States Patient Derived Xenograft/PDX Models Market Share by Type (2016-2020)
Table United States Patient Derived Xenograft/PDX Models Market Size by Application (2016-2020) (Million US$)
Table United States Patient Derived Xenograft/PDX Models Market Share by Application (2016-2020)
Figure Europe Patient Derived Xenograft/PDX Models Market Size 2016-2020 (Million US$)
Table Europe Key Players Patient Derived Xenograft/PDX Models Revenue (2020) (Million US$)
Table Europe Key Players Patient Derived Xenograft/PDX Models Market Share (2020)
Table Europe Patient Derived Xenograft/PDX Models Market Size by Type (2016-2020) (Million US$)
Table Europe Patient Derived Xenograft/PDX Models Market Share by Type (2016-2020)
Table Europe Patient Derived Xenograft/PDX Models Market Size by Application (2016-2020) (Million US$)
Table Europe Patient Derived Xenograft/PDX Models Market Share by Application (2016-2020)
Figure China Patient Derived Xenograft/PDX Models Market Size 2016-2020 (Million US$)
Table China Key Players Patient Derived Xenograft/PDX Models Revenue (2020) (Million US$)
Table China Key Players Patient Derived Xenograft/PDX Models Market Share (2020)
Table China Patient Derived Xenograft/PDX Models Market Size by Type (2016-2020) (Million US$)
Table China Patient Derived Xenograft/PDX Models Market Share by Type (2016-2020)
Table China Patient Derived Xenograft/PDX Models Market Size by Application (2016-2020) (Million US$)
Table China Patient Derived Xenograft/PDX Models Market Share by Application (2016-2020)
Figure Japan Patient Derived Xenograft/PDX Models Market Size 2016-2020 (Million US$)
Table Japan Key Players Patient Derived Xenograft/PDX Models Revenue (2020) (Million US$)
Table Japan Key Players Patient Derived Xenograft/PDX Models Market Share (2020)
Table Japan Patient Derived Xenograft/PDX Models Market Size by Type (2016-2020) (Million US$)
Table Japan Patient Derived Xenograft/PDX Models Market Share by Type (2016-2020)
Table Japan Patient Derived Xenograft/PDX Models Market Size by Application (2016-2020) (Million US$)
Table Japan Patient Derived Xenograft/PDX Models Market Share by Application (2016-2020)
Figure Southeast Asia Patient Derived Xenograft/PDX Models Market Size 2016-2020 (Million US$)
Table Southeast Asia Key Players Patient Derived Xenograft/PDX Models Revenue (2020) (Million US$)
Table Southeast Asia Key Players Patient Derived Xenograft/PDX Models Market Share (2020)
Table Southeast Asia Patient Derived Xenograft/PDX Models Market Size by Type (2016-2020) (Million US$)
Table Southeast Asia Patient Derived Xenograft/PDX Models Market Share by Type (2016-2020)
Table Southeast Asia Patient Derived Xenograft/PDX Models Market Size by Application (2016-2020) (Million US$)
Table Southeast Asia Patient Derived Xenograft/PDX Models Market Share by Application (2016-2020)
Figure India Patient Derived Xenograft/PDX Models Market Size 2016-2020 (Million US$)
Table India Key Players Patient Derived Xenograft/PDX Models Revenue (2020) (Million US$)
Table India Key Players Patient Derived Xenograft/PDX Models Market Share (2020)
Table India Patient Derived Xenograft/PDX Models Market Size by Type (2016-2020) (Million US$)
Table India Patient Derived Xenograft/PDX Models Market Share by Type (2016-2020)
Table India Patient Derived Xenograft/PDX Models Market Size by Application (2016-2020) (Million US$)
Table India Patient Derived Xenograft/PDX Models Market Share by Application (2016-2020)
Figure Central & South America Patient Derived Xenograft/PDX Models Market Size 2016-2020 (Million US$)
Table Central & South America Key Players Patient Derived Xenograft/PDX Models Revenue (2020) (Million US$)
Table Central & South America Key Players Patient Derived Xenograft/PDX Models Market Share (2020)
Table Central & South America Patient Derived Xenograft/PDX Models Market Size by Type (2016-2020) (Million US$)
Table Central & South America Patient Derived Xenograft/PDX Models Market Share by Type (2016-2020)
Table Central & South America Patient Derived Xenograft/PDX Models Market Size by Application (2016-2020) (Million US$)
Table Central & South America Patient Derived Xenograft/PDX Models Market Share by Application (2016-2020)
Table Crown Bioscience Company Details
Table Crown Bioscience Revenue in Patient Derived Xenograft/PDX Models Business (2020) (Million US$)
Figure Crown Bioscience Revenue Growth Rate in Patient Derived Xenograft/PDX Models Business (2020)
Table Crown Bioscience Recent Development
Table The Jackson Laboratory Company Details
Table The Jackson Laboratory Revenue in Patient Derived Xenograft/PDX Models Business (2020)(Million US$)
Figure The Jackson Laboratory Revenue Growth Rate in Patient Derived Xenograft/PDX Models Business (2020)
Table The Jackson Laboratory Recent Development
Table Champions Oncology Company Details
Table Champions Oncology Revenue in Patient Derived Xenograft/PDX Models Business (2020)(Million US$)
Figure Champions Oncology Revenue Growth Rate in Patient Derived Xenograft/PDX Models Business (2020)
Table Champions Oncology Recent Development
Table Charles River Laboratories Company Details
Table Charles River Laboratories Revenue in Patient Derived Xenograft/PDX Models Business (2020)(Million US$)
Figure Charles River Laboratories Revenue Growth Rate in Patient Derived Xenograft/PDX Models Business (2020)
Table Charles River Laboratories Recent Development
Table WuXi Apptec Company Details
Table WuXi Apptec Revenue in Patient Derived Xenograft/PDX Models Business (2020)(Million US$)
Figure WuXi Apptec Revenue Growth Rate in Patient Derived Xenograft/PDX Models Business (2020)
Table WuXi Apptec Recent Development
Table Oncodesign Company Details
Table Oncodesign Revenue in Patient Derived Xenograft/PDX Models Business (2020)(Million US$)
Figure Oncodesign Revenue Growth Rate in Patient Derived Xenograft/PDX Models Business (2020)
Table Oncodesign Recent Development
Table Horizon Discovery Company Details
Table Horizon Discovery Revenue in Patient Derived Xenograft/PDX Models Business (2020)(Million US$)
Figure Horizon Discovery Revenue Growth Rate in Patient Derived Xenograft/PDX Models Business (2020)
Table Horizon Discovery Recent Development
Table Pharmatest Services Company Details
Table Pharmatest Services Revenue in Patient Derived Xenograft/PDX Models Business (2020)(Million US$)
Figure Pharmatest Services Revenue Growth Rate in Patient Derived Xenograft/PDX Models Business (2020)
Table Pharmatest Services Recent Development
Table Hera Biolabs Company Details
Table Hera Biolabs Revenue in Patient Derived Xenograft/PDX Models Business (2020)(Million US$)
Figure Hera Biolabs Revenue Growth Rate in Patient Derived Xenograft/PDX Models Business (2020)
Table Hera Biolabs Recent Development
Table EPO Berlin-Buch Company Details
Table EPO Berlin-Buch Revenue in Patient Derived Xenograft/PDX Models Business (2020)(Million US$)
Figure EPO Berlin-Buch Revenue Growth Rate in Patient Derived Xenograft/PDX Models Business (2020)
Table EPO Berlin-Buch Recent Development
Table Xentech Company Details
Table Urolead Company Details
Table Global Patient Derived Xenograft/PDX Models Market Size by Regions (Million US$) 2021-2027
Figure Global Patient Derived Xenograft/PDX Models Market Size Share by Regions (2021-2027)
Figure Global Patient Derived Xenograft/PDX Models Market Size Share by Regions in 2027
Figure United States Patient Derived Xenograft/PDX Models Market Size Forecast (2021-2027)(Million USD)
Figure Europe Patient Derived Xenograft/PDX Models Market Size Forecast (2021-2027)(Million USD)
Figure China Patient Derived Xenograft/PDX Models Market Size Forecast (2021-2027)(Million USD)
Figure Japan Patient Derived Xenograft/PDX Models Market Size Forecast (2021-2027)(Million USD)
Figure Southeast Asia Patient Derived Xenograft/PDX Models Market Size Forecast (2021-2027)(Million USD)
Figure India Patient Derived Xenograft/PDX Models Market Size Forecast (2021-2027)(Million USD)
Figure Central & South America Patient Derived Xenograft/PDX Models Market Size Forecast (2021-2027)(Million USD)
Table Global Patient Derived Xenograft/PDX Models Market Size by Product (2021-2027) (Million US$)
Figure Global Patient Derived Xenograft/PDX Models Market Size by Product (2021-2027)
Figure Global Patient Derived Xenograft/PDX Models Market Size by Product in 2027
Table Global Patient Derived Xenograft/PDX Models Market Size by Application (2021-2027) (Million US$)
Figure Global Patient Derived Xenograft/PDX Models Market Size by Application (2021-2027)
Figure Global Patient Derived Xenograft/PDX Models Market Size by Application in 2027
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources